[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021 1Q21 Added 17,233 New Subscribers Revenues Up 2.8% YoY to RMB280.9 Million ($39.8 Million) Gross Profit Up 4.3% YoY to RMB237.5 million ($33.6 million) Operating Income Up 18.8% YoY to RMB133.5 Million ($18.]
[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021 1Q21 Added 17,233 New Subscribers Revenues Up 2.8% YoY to RMB280.9 Million ($39.8 Million) Gross Profit Up 4.3% YoY to RMB237.5 million ($33.6 million) Operating Income Up 18.8% YoY to RMB133.5 Million ($18.]
[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen]
[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen]
[Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020 Added 18,488 New Subscribers in 4Q20 4Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million) 4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million) N]
[Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020 Added 18,488 New Subscribers in 4Q20 4Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million) 4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million) N]
[Global Cord Blood Corporation Provides Further Update on COVID-19 HONG KONG, China, April 27, 2020 Global Cord Blood Corporation (NYSE: CO) (GCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage ser]
[Global Cord Blood Corporation Provides Further Update on COVID-19 HONG KONG, China, April 27, 2020 Global Cord Blood Corporation (NYSE: CO) (GCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage ser]
[Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 3Q20 Added 23,387 New Subscribers Revenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million) Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income U]
[Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 3Q20 Added 23,387 New Subscribers Revenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million) Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income U]
